Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients.
Madreiter-Sokolowski CT, Győrffy B, Klec C, Sokolowski AA, Rost R, Waldeck-Weiermair M, Malli R, Graier WF. Madreiter-Sokolowski CT, et al. Among authors: gyorffy b. Oncotarget. 2017 Aug 28;8(46):80278-80285. doi: 10.18632/oncotarget.20571. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113301 Free PMC article.
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer.
Magnani L, Patten DK, Nguyen VT, Hong SP, Steel JH, Patel N, Lombardo Y, Faronato M, Gomes AR, Woodley L, Page K, Guttery D, Primrose L, Fernandez Garcia D, Shaw J, Viola P, Green A, Nolan C, Ellis IO, Rakha EA, Shousha S, Lam EW, Győrffy B, Lupien M, Coombes RC. Magnani L, et al. Among authors: gyorffy b. Oncotarget. 2015 Sep 8;6(26):21878-91. doi: 10.18632/oncotarget.4243. Oncotarget. 2015. PMID: 26215677 Free PMC article.
Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
Giordano C, Chemi F, Panza S, Barone I, Bonofiglio D, Lanzino M, Cordella A, Campana A, Hashim A, Rizza P, Leggio A, Győrffy B, Simões BM, Clarke RB, Weisz A, Catalano S, Andò S. Giordano C, et al. Among authors: gyorffy b. Oncotarget. 2016 Jan 12;7(2):1262-75. doi: 10.18632/oncotarget.6014. Oncotarget. 2016. PMID: 26556856 Free PMC article.
Potential options for managing LOX+ ER- breast cancer patients.
Han Y, Lian S, Cui X, Meng K, Győrffy B, Jin T, Huang D. Han Y, et al. Among authors: gyorffy b. Oncotarget. 2016 May 31;7(22):32893-901. doi: 10.18632/oncotarget.9073. Oncotarget. 2016. PMID: 27147578 Free PMC article.
TP53 mutation hits energy metabolism and increases glycolysis in breast cancer.
Harami-Papp H, Pongor LS, Munkácsy G, Horváth G, Nagy ÁM, Ambrus A, Hauser P, Szabó A, Tretter L, Győrffy B. Harami-Papp H, et al. Among authors: gyorffy b. Oncotarget. 2016 Oct 11;7(41):67183-67195. doi: 10.18632/oncotarget.11594. Oncotarget. 2016. PMID: 27582538 Free PMC article.
LDB1 overexpression is a negative prognostic factor in colorectal cancer.
García SA, Swiersy A, Radhakrishnan P, Branchi V, Kanth Nanduri L, Győrffy B, Betzler AM, Bork U, Kahlert C, Reißfelder C, Rahbari NN, Weitz J, Schölch S. García SA, et al. Among authors: gyorffy b. Oncotarget. 2016 Dec 20;7(51):84258-84270. doi: 10.18632/oncotarget.12481. Oncotarget. 2016. PMID: 27713177 Free PMC article.
435 results